Review





Similar Products

95
ABclonal Biotechnology erk1 2
IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Erk1 2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/Phospho-Erk1-T202%2FY204+%2B+Erk2-T185%2FY187+Rabbit+mAb/pmc13689533-35-47-53
Average 95 stars, based on 1 article reviews
erk1 2 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
ABclonal Biotechnology rabbit phospho erk1 2 mab
IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Rabbit Phospho Erk1 2 Mab, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/Phospho-Erk1-T202%2FY204+%2B+Erk2-T185%2FY187+Rabbit+mAb/10__1186_slash_s12974___026___04075___9-105-50-55
Average 95 stars, based on 1 article reviews
rabbit phospho erk1 2 mab - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
ABclonal Biotechnology p erk1 2
IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
P Erk1 2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/Phospho-ERK1-T202+%2B+ERK2-T185+Rabbit+mAb/10__3390_slash_biom16101464-86-21-24
Average 94 stars, based on 1 article reviews
p erk1 2 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
ABclonal Biotechnology p erk1
IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
P Erk1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/Phospho-Erk1-T202%2FY204+%2B+Erk2-T185%2FY187+Rabbit+mAb/10__1186_slash_s40001___026___05241___8-145-67-69
Average 95 stars, based on 1 article reviews
p erk1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
ABclonal Biotechnology p erk2
IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
P Erk2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/Phospho-ERK1-T202+%2B+ERK2-T185+Rabbit+mAb/10__1186_slash_s40001___026___05241___8-145-81-83
Average 94 stars, based on 1 article reviews
p erk2 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
ABclonal Biotechnology erk2
IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Erk2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/%5BKO+Validated%5D+ERK2+Rabbit+mAb/10__1186_slash_s40001___026___05241___8-145-86-88
Average 92 stars, based on 1 article reviews
erk2 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

98
MedChemExpress erk2 phosphorylation inhibitor
IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Erk2 Phosphorylation Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/SCH772984/10__1186_slash_s40001___026___05241___8-109-13-17
Average 98 stars, based on 1 article reviews
erk2 phosphorylation inhibitor - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc erk2
(A) LFC plot in KRAS mut PDAC versus all other lines. (B) Volcano plot of differential LFC in KRAS mut PDAC versus all other lines. Y-axis shows statistical significance (-log 10 p value). Horizontal dashed line marks p = 0.001. (C) Differential synergy map showing all gene pairs with differential Combinatory score ≤ -1 in KRAS mut PDAC versus all other lines. (D-E) Boxplots display LFC scores for KRAS_FRS2 (D) and KRAS_EGFR (E) and corresponding single genes, separated into KRAS mut PDAC, KRAS mut CRC, and KRAS WT lines. (F) <t>siRNA</t> dual knockdown of KRAS and FGFR-pathway genes leads to significantly reduced growth versus single knockdown in SNU410 cells. Cell growth was assayed using Incucyte and normalized to timepoint 0. Data represent mean ± SD. P values calculated by extra sum-of-squares F test comparing growth rate constants of exponential growth curve fits. Single gene knockdowns were compared versus siNT/siNT, and dual gene knockdowns were compared versus siKRAS/siNT. ***: P < 0.001, NS: P > 0.05. (G) Zoldonrasib dose-response curve of PANC0203 cells with or without doxycycline induction of an <t>shRNA</t> targeting FRS2. Viability measured by CellTiter-Glo. Data represent mean ± SD.
Erk2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/MEK1+Mouse+mAb/bio_rxiv__64898__2026__09__24__754062-357-38-40
Average 95 stars, based on 1 article reviews
erk2 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
ABclonal Biotechnology perk
(A) LFC plot in KRAS mut PDAC versus all other lines. (B) Volcano plot of differential LFC in KRAS mut PDAC versus all other lines. Y-axis shows statistical significance (-log 10 p value). Horizontal dashed line marks p = 0.001. (C) Differential synergy map showing all gene pairs with differential Combinatory score ≤ -1 in KRAS mut PDAC versus all other lines. (D-E) Boxplots display LFC scores for KRAS_FRS2 (D) and KRAS_EGFR (E) and corresponding single genes, separated into KRAS mut PDAC, KRAS mut CRC, and KRAS WT lines. (F) <t>siRNA</t> dual knockdown of KRAS and FGFR-pathway genes leads to significantly reduced growth versus single knockdown in SNU410 cells. Cell growth was assayed using Incucyte and normalized to timepoint 0. Data represent mean ± SD. P values calculated by extra sum-of-squares F test comparing growth rate constants of exponential growth curve fits. Single gene knockdowns were compared versus siNT/siNT, and dual gene knockdowns were compared versus siKRAS/siNT. ***: P < 0.001, NS: P > 0.05. (G) Zoldonrasib dose-response curve of PANC0203 cells with or without doxycycline induction of an <t>shRNA</t> targeting FRS2. Viability measured by CellTiter-Glo. Data represent mean ± SD.
Perk, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/Phospho-ERK1-T202%2FY204+%2B+ERK2-T185%2FY187+Rabbit+pAb/pm42789015-102-48-50
Average 95 stars, based on 1 article reviews
perk - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology erk2
(A) Relative mRNA expression of IGFBP3 and IGFBP5 in control, PAE-L, and PAE-M newborn mammary tissues determined by quantitative RT-PCR. (B) Representative Western blots of selected insulin/IGF- and growth-factor-associated signaling proteins, including p-IRS1(T895), p-IRS1(S612), IRS1, EGFR, ErbB3, IGF1R, p-Akt1(S473), Akt1, p-ERK1/2, <t>ERK2,</t> ERα, Sox2, and IGFBP5. (C) Densitometric analysis of Western blot data. Phosphorylated proteins were normalized to their corresponding total proteins, and total protein levels were normalized to β-Actin, as appropriate.
Erk2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk2/ERK+2+Antibody/bio_rxiv__64898__2026__09__22__753596-79-30-44
Average 96 stars, based on 1 article reviews
erk2 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: Immunity, Inflammation and Disease

Article Title: Interleukin‐35 Ameliorates Obesity‐Associated Impairment of Endothelium‐Dependent Vasodilation via the STAT3‐MAPK/ERK‐eNOS Signaling Axis

doi: 10.1002/iid3.70564

Figure Lengend Snippet: IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: Primary antibodies for immunofluorescence and Western blotting: EBI3 (12371‐1‐AP), IL‐12A (85754‐2‐RR), platelet endothelial cell adhesion molecule‐1 (PECAM‐1/CD31) (11265‐1‐AP), eNOS (27120‐1‐AP), and β‐tubulin (66240‐1‐Ig) from Proteintech (USA); p‐eNOS (Ser1177, #9571), p‐cRAF (#9427), p‐MEK1/2 (#9154), and p‐STAT3 (#9145) from Cell Signaling Technology (USA); cRAF (A19638), MEK1/2 (A4868), p‐ERK1/2 (AP0974), ERK1/2 (A4782), and STAT3 (A1192) from ABclonal Technology (China).

Techniques: Phospho-proteomics, Western Blot, Analysis, Fluorescence

(A) LFC plot in KRAS mut PDAC versus all other lines. (B) Volcano plot of differential LFC in KRAS mut PDAC versus all other lines. Y-axis shows statistical significance (-log 10 p value). Horizontal dashed line marks p = 0.001. (C) Differential synergy map showing all gene pairs with differential Combinatory score ≤ -1 in KRAS mut PDAC versus all other lines. (D-E) Boxplots display LFC scores for KRAS_FRS2 (D) and KRAS_EGFR (E) and corresponding single genes, separated into KRAS mut PDAC, KRAS mut CRC, and KRAS WT lines. (F) siRNA dual knockdown of KRAS and FGFR-pathway genes leads to significantly reduced growth versus single knockdown in SNU410 cells. Cell growth was assayed using Incucyte and normalized to timepoint 0. Data represent mean ± SD. P values calculated by extra sum-of-squares F test comparing growth rate constants of exponential growth curve fits. Single gene knockdowns were compared versus siNT/siNT, and dual gene knockdowns were compared versus siKRAS/siNT. ***: P < 0.001, NS: P > 0.05. (G) Zoldonrasib dose-response curve of PANC0203 cells with or without doxycycline induction of an shRNA targeting FRS2. Viability measured by CellTiter-Glo. Data represent mean ± SD.

Journal: bioRxiv

Article Title: Context-specific genetic interaction mapping reveals combinatorial KRAS/FGFR dependence in pancreatic cancer

doi: 10.64898/2026.09.24.754062

Figure Lengend Snippet: (A) LFC plot in KRAS mut PDAC versus all other lines. (B) Volcano plot of differential LFC in KRAS mut PDAC versus all other lines. Y-axis shows statistical significance (-log 10 p value). Horizontal dashed line marks p = 0.001. (C) Differential synergy map showing all gene pairs with differential Combinatory score ≤ -1 in KRAS mut PDAC versus all other lines. (D-E) Boxplots display LFC scores for KRAS_FRS2 (D) and KRAS_EGFR (E) and corresponding single genes, separated into KRAS mut PDAC, KRAS mut CRC, and KRAS WT lines. (F) siRNA dual knockdown of KRAS and FGFR-pathway genes leads to significantly reduced growth versus single knockdown in SNU410 cells. Cell growth was assayed using Incucyte and normalized to timepoint 0. Data represent mean ± SD. P values calculated by extra sum-of-squares F test comparing growth rate constants of exponential growth curve fits. Single gene knockdowns were compared versus siNT/siNT, and dual gene knockdowns were compared versus siKRAS/siNT. ***: P < 0.001, NS: P > 0.05. (G) Zoldonrasib dose-response curve of PANC0203 cells with or without doxycycline induction of an shRNA targeting FRS2. Viability measured by CellTiter-Glo. Data represent mean ± SD.

Article Snippet: Membranes were probed with antibodies against pFGFR (1:250; CST, #3471), pAKT (1:250; CST, #13038), AKT (1:1000; CST, #2920), pERK (1:250; CST, #5726), ERK (1:1000; CST, #4695), RAS (1:1000; CST, #67648), GAPDH (1:2500; CST, #2118), MEK1 (1:1000; CST, #2352), ERK2 (1:1000; CST, #9108), or Vinculin (1:5000; Sigma-Aldrich, V9264), followed by incubation with fluorescent secondary antibodies.

Techniques: Knockdown, shRNA

(A) Relative mRNA expression of IGFBP3 and IGFBP5 in control, PAE-L, and PAE-M newborn mammary tissues determined by quantitative RT-PCR. (B) Representative Western blots of selected insulin/IGF- and growth-factor-associated signaling proteins, including p-IRS1(T895), p-IRS1(S612), IRS1, EGFR, ErbB3, IGF1R, p-Akt1(S473), Akt1, p-ERK1/2, ERK2, ERα, Sox2, and IGFBP5. (C) Densitometric analysis of Western blot data. Phosphorylated proteins were normalized to their corresponding total proteins, and total protein levels were normalized to β-Actin, as appropriate.

Journal: bioRxiv

Article Title: Transcriptomic Analysis of the Newborn Mammary Gland Identifies Prenatal Ethanol-Induced Remodeling of Insulin Signaling and Enhanced Proliferative Programming

doi: 10.64898/2026.09.22.753596

Figure Lengend Snippet: (A) Relative mRNA expression of IGFBP3 and IGFBP5 in control, PAE-L, and PAE-M newborn mammary tissues determined by quantitative RT-PCR. (B) Representative Western blots of selected insulin/IGF- and growth-factor-associated signaling proteins, including p-IRS1(T895), p-IRS1(S612), IRS1, EGFR, ErbB3, IGF1R, p-Akt1(S473), Akt1, p-ERK1/2, ERK2, ERα, Sox2, and IGFBP5. (C) Densitometric analysis of Western blot data. Phosphorylated proteins were normalized to their corresponding total proteins, and total protein levels were normalized to β-Actin, as appropriate.

Article Snippet: Proteins examined included IRS1(#3407), phospho-IRS1 (Ser612) (#3203), phospho-IRS1 (Tyr895) (#3070), phospho-Akt1 (Ser473) (#4060), ErbB3 (#12708), phospho-ERK1/2 (Thr202/Tyr204) (#9101) were purchased from Cell signaling Technology, EGFR (sc-03), IGF1R (sc-712), Akt1 (sc-5298), Erk2 (sc-1647), ERα (sc-8002), Sox2 (sc-398254), IGFBP5 (sc-515116) and β-Actin (sc-47778) were purchased from Santa Cruz Biotechnology.

Techniques: Expressing, Control, Quantitative RT-PCR, Western Blot, Analysis